Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SureGene
AddedFeb 18, 2024
UpdatedJun 18, 2026
SureGene

SureGene

Angel

SureGene, LLC: Advancing psychiatric care through genetic-based molecular diagnostic tools.

HQ
Louisville, KY, US
Founded
2004
Overview
Compare
Fundraising
Employees

Louisville, Kentucky based SureGene, LLC utilizes modern genetic technology to discover the underlying genetic basis for psychiatric illnesses and drug response.

They develop their genetic discoveries into products (molecular diagnostic tests) used to improve the care of people with serious mental illness.

SureGene - Similar Companies

Geneticure logo

Geneticure

geneticure.com

Genomind logo

Genomind

genomind.com

Gene Solutions logo

Gene Solutions

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Sundance Diagnostics logo

Sundance Diagnostics

sundancedx.com

Geneicd logo

Geneicd

Myriad Genetics logo

Myriad Genetics

myriad.com

Iverson Genetic Diagnostics logo

Iverson Genetic Diagnostics

Genendeavor logo

Genendeavor

genendeavor.com

ThinkGenetic logo

ThinkGenetic

thinkgenetic.com

DxNA logo

DxNA

My Gene Counsel logo

My Gene Counsel

mygenecounsel.com

Circular Genomics logo

Circular Genomics

Genetica logo

Genetica

genetica.asia

PanGenX logo

PanGenX

SureGene - Quick Facts

Who are SureGene's competitors?

Companies similar to SureGene include Geneticure, Genomind, Gene Solutions and GeneDx Holdings.

When was SureGene founded?

SureGene was founded in 2004.

Where is SureGene's headquarters located?

SureGene's headquarters is located in Louisville, KY, US.

When was SureGene's last funding round?

SureGene's most recent funding round was for $400k (USD) in May 2009.

How much has SureGene raised to-date?

As of May 14, 2009, SureGene has raised a total of $400k (USD).

How many employees does SureGene have?

SureGene has 5 employees as of Feb 5, 2024.

SureGene - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Diagnostic Tests
Tags
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 6 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified